These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12630391)

  • 21. Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 Sep; 78(36):315-7. PubMed ID: 14518107
    [No Abstract]   [Full Text] [Related]  

  • 22. Pacific collaboration to eliminate lymphatic filariasis.
    Ichimori K; Crump A
    Trends Parasitol; 2005 Oct; 21(10):441-4. PubMed ID: 16099721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass drug treatment for lymphatic filariasis and onchocerciasis.
    Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
    Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
    [No Abstract]   [Full Text] [Related]  

  • 24. Twelve-month longitudinal parasitological assessment of lymphatic filariasis-positive individuals: impact of a biannual treatment with ivermectin and albendazole.
    Kanamitie JN; Ahorlu CS; Otchere J; Aboagye-Antwi F; Kwansa-Bentum B; Boakye DA; Biritwum NK; Wilson MD; de Souza DK
    Trop Med Int Health; 2017 Nov; 22(11):1451-1456. PubMed ID: 28891597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of lymphatic filariasis: a public-health challenge.
    Zagaria N; Savioli L
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S3-13. PubMed ID: 12630389
    [No Abstract]   [Full Text] [Related]  

  • 26. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2009 Oct; 84(42):437-44. PubMed ID: 19860021
    [No Abstract]   [Full Text] [Related]  

  • 27. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2010 Sep; 85(38):365-72. PubMed ID: 20853547
    [No Abstract]   [Full Text] [Related]  

  • 28. The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific.
    Rainima-Qaniuci M; Lepaitai HB; Bhagirov R; Padmasiri E; Naseri T; Thomsen R; Won KY; Brant TA; Dodd E; Nua MT; Utu F; Tufa A; Chutaro E; Camacho J; Suiaunoa-Scanlan L; Thean LJ; Mani J; Hardy M; Samuela J; Romani L; Kaldor J; Steer AC; Faktaufon D; Bechu V; Naqio F; Sosene V; Sekihara M; Otaki J; Buhagiar TS; Yajima A
    Am J Trop Med Hyg; 2022 May; 106(5_Suppl):39-47. PubMed ID: 35292579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
    Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
    Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerating the Uptake of WHO Recommendations for Mass Drug Administration Using Ivermectin, Diethylcarbamazine, and Albendazole.
    King JD; Jacobson J; Krentel A
    Am J Trop Med Hyg; 2022 May; 106(5_Suppl):26-28. PubMed ID: 35292578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albendazole for the control and elimination of lymphatic filariasis: systematic review.
    Critchley J; Addiss D; Ejere H; Gamble C; Garner P; Gelband H;
    Trop Med Int Health; 2005 Sep; 10(9):818-25. PubMed ID: 16135187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies and tools for the control/elimination of lymphatic filariasis.
    Ottesen EA; Duke BO; Karam M; Behbehani K
    Bull World Health Organ; 1997; 75(6):491-503. PubMed ID: 9509621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albendazole for lymphatic filariasis.
    Addiss D; Critchley J; Ejere H; Garner P; Gelband H; Gamble C;
    Cochrane Database Syst Rev; 2004; (1):CD003753. PubMed ID: 14974034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
    Fischer PU; King CL; Jacobson JA; Weil GJ
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
    [No Abstract]   [Full Text] [Related]  

  • 35. Albendazole for lymphatic filariasis.
    Critchley J; Addiss D; Gamble C; Garner P; Gelband H; Ejere H;
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003753. PubMed ID: 16235339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global programme to eliminate lymphatic filariasis.
    World Health Organization
    Wkly Epidemiol Rec; 2005 Jun; 80(23):202-12. PubMed ID: 16033148
    [No Abstract]   [Full Text] [Related]  

  • 37. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P; Supali T; Maizels RM
    Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Migration and dispersal of lymphatic filariasis in Papua New Guinea.
    Alexander ND; Bockarie MJ; Dimber ZB; Griffin L; Kazura JW; Alpers MP
    Trans R Soc Trop Med Hyg; 2001; 95(3):277-9. PubMed ID: 11490996
    [No Abstract]   [Full Text] [Related]  

  • 39. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
    Nandha B; Krishnamoorthy K; Jambulingam P
    Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
    Burkot TR; Taleo G; Toeaso V; Ichimori K
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.